This post has been archived and contains information that may be out of date.
Earlier this week, the Office of Health Care Affordability released a revised draft regulation on the cost and market impact review process. The revised draft regulations include several notable improvements compared to the prior version, most notably exempting from review transactions in the usual and regular course of business and establishing an expedited review process for transactions that include a financially distressed health care entity.
Despite these improvements, CHA has a number of outstanding concerns with the revised draft regulations and will be issuing comments before the comment period closes on Oct. 17 at 5 p.m. (PT).
